200 related articles for article (PubMed ID: 24218572)
1. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.
Guen VJ; Gamble C; Flajolet M; Unger S; Thollet A; Ferandin Y; Superti-Furga A; Cohen PA; Meijer L; Colas P
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19525-30. PubMed ID: 24218572
[TBL] [Abstract][Full Text] [Related]
2. STAR syndrome-associated CDK10/Cyclin M regulates actin network architecture and ciliogenesis.
Guen VJ; Gamble C; Perez DE; Bourassa S; Zappel H; Gärtner J; Lees JA; Colas P
Cell Cycle; 2016; 15(5):678-88. PubMed ID: 27104747
[TBL] [Abstract][Full Text] [Related]
3. Ocular manifestations of X-linked dominant FAM58A mutation in toe syndactyly, telecanthus, anogenital, and renal malformations ('STAR') syndrome.
Orge FH; Dar SA; Blackburn CN; Grimes-Hodges SJ; Mitchell AL
Ophthalmic Genet; 2016 Sep; 37(3):323-7. PubMed ID: 26882209
[TBL] [Abstract][Full Text] [Related]
4. The awakening of the CDK10/Cyclin M protein kinase.
Guen VJ; Gamble C; Lees JA; Colas P
Oncotarget; 2017 Jul; 8(30):50174-50186. PubMed ID: 28178678
[TBL] [Abstract][Full Text] [Related]
5. STAR syndrome plus: The first description of a female patient with the lethal form.
Bedeschi MF; Giangiobbe S; Paganini L; Tabano S; Silipigni R; Colombo L; Crippa BL; Lalatta F; Guerneri S; Miozzo M
Am J Med Genet A; 2017 Dec; 173(12):3226-3230. PubMed ID: 29088509
[TBL] [Abstract][Full Text] [Related]
6. Multigenerational pedigree with STAR syndrome: A novel FAM58A variant and expansion of the phenotype.
Boczek NJ; Kruisselbrink T; Cousin MA; Blackburn PR; Klee EW; Gavrilova RH; Lanpher BC
Am J Med Genet A; 2017 May; 173(5):1328-1333. PubMed ID: 28322501
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the cyclin family member FAM58A cause an X-linked dominant disorder characterized by syndactyly, telecanthus and anogenital and renal malformations.
Unger S; Böhm D; Kaiser FJ; Kaulfuss S; Borozdin W; Buiting K; Burfeind P; Böhm J; Barrionuevo F; Craig A; Borowski K; Keppler-Noreuil K; Schmitt-Mechelke T; Steiner B; Bartholdi D; Lemke J; Mortier G; Sandford R; Zabel B; Superti-Furga A; Kohlhase J
Nat Genet; 2008 Mar; 40(3):287-9. PubMed ID: 18297069
[TBL] [Abstract][Full Text] [Related]
8. Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle.
Bagella L; Giacinti C; Simone C; Giordano A
J Cell Biochem; 2006 Oct; 99(3):978-85. PubMed ID: 16741970
[TBL] [Abstract][Full Text] [Related]
9. CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
Zhang X; Zhao Y; Yiminniyaze R; Zhu N; Zhang Y; Wumaier G; Xia J; Dong L; Zhou D; Wang J; Li C; Zhang Y; Li S
Mol Carcinog; 2024 Jan; 63(1):61-74. PubMed ID: 37737453
[TBL] [Abstract][Full Text] [Related]
10. STAR syndrome: a further case and the first report of maternal mosaicism.
Lefroy H; Hurst JA; Shears DJ
Clin Dysmorphol; 2017 Jul; 26(3):157-160. PubMed ID: 28225384
[No Abstract] [Full Text] [Related]
11. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.
Kasten M; Giordano A
Oncogene; 2001 Apr; 20(15):1832-8. PubMed ID: 11313931
[TBL] [Abstract][Full Text] [Related]
12. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders.
Robert T; Dock-Bregeon AC; Colas P
Mol Genet Genomic Med; 2021 Oct; 9(10):e1782. PubMed ID: 34369103
[TBL] [Abstract][Full Text] [Related]
14. Association of Cyclin Dependent Kinase 10 and Transcription Factor 2 during Human Corneal Epithelial Wound Healing in vitro model.
Zehra M; Mushtaq S; Ghulam Musharraf S; Ghani R; Ahmed N
Sci Rep; 2019 Aug; 9(1):11802. PubMed ID: 31413335
[TBL] [Abstract][Full Text] [Related]
15. Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.
Iorns E; Turner NC; Elliott R; Syed N; Garrone O; Gasco M; Tutt AN; Crook T; Lord CJ; Ashworth A
Cancer Cell; 2008 Feb; 13(2):91-104. PubMed ID: 18242510
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the human Cdk10/Cyclin Q complex.
Düster R; Ji Y; Pan KT; Urlaub H; Geyer M
Open Biol; 2022 Mar; 12(3):210381. PubMed ID: 35291876
[TBL] [Abstract][Full Text] [Related]
17. STAR syndrome is part of the differential diagnosis of females with anorectal malformations.
Zarate YA; Farrell JM; Alfaro MP; Elhassan NO
Am J Med Genet A; 2015 Aug; 167A(8):1940-3. PubMed ID: 25845904
[No Abstract] [Full Text] [Related]
18. Knockdown of cyclin-dependent kinase 10 (cdk10) gene impairs neural progenitor survival via modulation of raf1a gene expression.
Yeh CW; Kao SH; Cheng YC; Hsu LS
J Biol Chem; 2013 Sep; 288(39):27927-39. PubMed ID: 23902762
[TBL] [Abstract][Full Text] [Related]
19. The identification of a novel CCNQ gene tail extension variant contributing to syndactyly, telecanthus and anogenital and renal malformations syndrome.
Che R; Wang C; Huang S; Zheng B; Li H; Cheng X; Zhao F; Ding G; Jia Z; Zhang A
Clin Genet; 2023 Feb; 103(2):179-189. PubMed ID: 36284407
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic approach in the characterization of newborns with anorectal malformation.
Schierz IAM; Piro E; Giuffrè M; Pinello G; Angelini A; Antona V; Cimador M; Corsello G
J Matern Fetal Neonatal Med; 2022 Dec; 35(23):4513-4520. PubMed ID: 36062518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
